首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries
【2h】

Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries

机译:氧化还原化合物对硝基血管舒张性大鼠冠状动脉舒张的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">Various classes of nitrovasodilators release nitric oxide (NO) through distinct reaction pathways, many of which involve endogenous reductants and/or oxidants. This study examined relaxations of isolated rat coronary arteries induced by spermine NONOate (SPNO), 3-morpholinosydnonimine (SIN-1), nitroprusside (NP), S-nitroso-N-acetylpenicillamine (SNAP) and nitroglycerin (NTG) in order to assess whether their potency was influenced by any of six redox compounds: 1 mM ascorbate, 1 mM dehydroascorbate, 0.1 mM dithiothreitol, 10 μM diamide, 0.1 mM ferrocyanide, and 0.1 mM ferricyanide.Only SPNO spontaneously generated NO at measurable levels. These levels were decreased by the presence of ascorbate and dithiothreitol, which likewise decreased the potency of SPNO.The potency of SIN-1 was unaffected by any redox compound except ferricyanide, which increased the potency not only of SIN-1, but also of other nitrovasodilators and NO-independent vasodilators.The potency of NP was decreased by two structurally similar multivalent anions, ferrocyanide and ferricyanide, suggesting that NP metabolism requires ionic binding to tissue.SNAP lost its potency in solutions containing ascorbate or dehydroascorbate. SNAP potency was also decreased by the glutathione oxidant, diamide, and by ferrocyanide and ferricyanide, suggesting that glutathione and ionic binding may be required for NO release.NTG appeared to relax arteries via two pathways. One required only low concentrations of NTG and a labile endogenous factor that was preserved by dithiothreitol and eliminated by ferricyanide. A distinct second pathway required higher concentrations of NTG.These distinct attributes of nitrovasodilator metabolism may underlie differences in regional specificity or tolerance development, and therefore might eventually be exploited in the development and use of nitrovasodilators.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 各种类型的硝化血管舒张剂通过不同的反应途径释放一氧化氮(NO),其中许多涉及内源性还原剂和/或氧化剂。这项研究检查了由精胺NONOate(SPNO),3-吗啉代亚胺(SIN-1),硝普钠(NP),S-亚硝基-N-乙酰青霉胺(SNAP)和硝化甘油(NTG)诱导的离体大鼠冠状动脉的松弛它们的效力是否受以下六种氧化还原化合物的影响:1 mM抗坏血酸盐,1 mM脱氢抗坏血酸盐,0.1 mM二硫苏糖醇,10μM二酰胺,0.1 mM亚铁氰化物和0.1 mM铁氰化物。可测量的水平。抗坏血酸和二硫苏糖醇的存在降低了这些水平,这同样降低了SPNO的效力。 除铁氰化物外,任何氧化还原化合物均不影响SIN-1的效力,不仅提高了SIN的效力-1,还有其他硝基血管扩张剂和非NO依赖性血管扩张剂。 两种结构相似的多价阴离子亚铁氰化物和铁氰化物会降低NP的效能,这表明NP代谢需要离子与组织结合。在含有抗坏血酸盐或脱氢抗坏血酸盐的溶液中,SNAP失去了效力。谷胱甘肽氧化剂,二酰胺,亚铁氰化物和铁氰化物也会使SNAP的能力降低,这说明NO释放可能需要谷胱甘肽和离子结合。 NTG似乎通过两条途径使动脉松弛。一个只需要低浓度的NTG和不稳定的内源性因子,该因子被二硫苏糖醇保存并被铁氰化物消除。另一个独特的途径需要更高浓度的NTG。 这些硝化血管扩张剂代谢的独特属性可能是区域特异性或耐受性差异的基础,因此最终可能会在硝化血管扩张剂的开发和使用中得到利用。 >

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号